Randall K. Wolf Named Ethicon Endo-Surgery Chair
Randall K. Wolf, MD, an internationally recognized pioneer in minimally invasive and robotic surgery, has been named to the newly established Ethicon Endo-Surgery Chair in the Department of Surgery at the UC College of Medicine.
Ethicon Endo-Surgery Inc. contributed funding to support the chair and UCs new Center for
Surgical Innovation (CSI).
With this new chair, Dr. Wolf is leading UC into discovery that directly translates into better care for patients, said Jeffrey Matthews, MD, Christian R. Holmes Professor and chair of UCs Department of Surgery.
Dr. Wolf, director of the CSI and professor of both surgery and biomedical engineering, was the first surgeon in the United States to use the da Vinci robotic surgical system for minimally invasive heart surgery.
He headed Ethicon Endo-Surgerys first training courses in minimally invasive thoracic surgery and has collaborated with the Blue Ash, Ohio, company on several new technologies.
Dr. Wolf also led the research team that developed the Wolf Mini Maze, a minimally invasive surgical procedure that cures an irregular heartbeat condition called atrial fibrillation, utilizing an endoscopic technique. Atrial fibrillation increases the risk of heart attack or stroke and affects 2.5 million Americans.
A native Cincinnatian, Dr. Wolf has performed minimally invasive heart surgery in more than 15 countries and trains cardiac surgeons from around the world in minimally invasive techniques.
He is the current president of the International Society of Minimally Invasive Cardiothoracic Society and president-elect of the 21st Century Cardiac Surgery Club.
Related Stories
UC's fourth-year medical students celebrate Match Day
March 24, 2025
At the University of Cincinnati's College of Medicine, 169 students gripped envelopes as they waited to learn their fate on Friday, along with thousands of other medical students across the country. Match Day is the milestone occasion when fourth-year medical students, along with their families, learn where they’ll be spending their residencies.
Add-on metformin promising in ER-positive endometrial cancer
March 24, 2025
The University of Cincinnati Cancer Center's Amanda Jackson was featured in a MedPage Today article commenting on new research that found adding metformin as a combination therapy was tied to deep responses and prolonged progression-free survival in some patients with recurrent estrogen receptor-positive endometrial cancer.
Cancer Center researcher studies unique behavior of pediatric...
March 24, 2025
The University of Cincinnati Cancer Center’s Timothy Phoenix, PhD; Pratiti (Mimi) Bandopadhayay, MBBS, PhD, of Dana-Farber Cancer Institute; and David Jones, PhD, of the German Cancer Research Center have been awarded a $1.2 million grant from the Team Jack Foundation to study pediatric low-grade gliomas.